Jonathan Slonin, Chief Medical Officer at Pacira BioSciences, Inc. (PCRX), sold 3,750 shares at $28.25 ($106K) on 2024-07-02, disclosed to the SEC on 2024-07-03.
Scheduled sale ($106k) by Chief Medical Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $28.46 | 914 | $26K | 24.5% |
| 2 | $28.25 | 2,836 | $80K | 75.5% |
| Total | $28.30 avg | 3,750 | $106K | 100% |
| Filing → |
| PCRX | SELL | 2025-11-19 | $191K | — | Filing → |
| PCRX | SELL | 2025-01-06 | $16K | — | Filing → |
| PCRX | SELL | 2024-08-02 | $19K | — | Filing → |